Increased tissue mRNA expression and urinary protein levels of MMP-2 were observed in glomerular damage in renal transplant rejection, FSGS, and glomerulosclerosis models [15, 29]. The gene discussed is MMP2; the disease is focal segmental glomerulosclerosis.